世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

【分析レポート:アプリケーション】慢性呼吸病:ウェアラブルモバイル医療機器市場の概観

Chronic Respiratory Disease: Wearable mHealth Device Market Overview

1Q 2017 | Application Analysis Report | AN-1554 | 25 pages | 4 tables | 6 charts | PDF

 

出版社 出版年月価格 ページ数図表数
ABI Research
ABIリサーチ
2017年2月お問い合わせください 25 10

サマリー

The wearable chronic respiratory disease device market is developing, with devices such as pulse oximeters, respiratory monitors, and air quality monitors being used by patients to track their vitals and detect any fluctuations or decline in health. A number of aspects are driving growth within the market, such as an increase of people with a chronic respiratory disease that requires monitoring, the current rising costs of providing care to these patients, and the need to track a patient’s vitals in real time throughout the day in order to predict and prevent a decline in health. This report examines the different types of devices within the wearable chronic respiratory disease device market, as well as outlining various major players. Forecasts include Wearable Chronic Respiratory Disease Device Shipments by Device Type, Wearable Chronic Respiratory Disease Device Revenue by Device Type, Wearable Chronic Respiratory Disease Device ASPs by Device Type, Chronic Obstructive Pulmonary Disease Deaths by Region, and Wearable Chronic Respiratory Disease Device Shipments by Region.



目次

  • 1. CHRONIC RESPIRATORY DISEASES
    • 1.1. Chronic Respiratory Disease
      • 1.1.1. Types of Chronic Respiratory Disease
      • 1.1.2. Treating and Monitoring Chronic Respiratory Diseases
    • 1.2. Wearable Chronic Respiratory Disease Monitoring
      • 1.2.1. Pulse Oximeters
      • 1.2.2. Respiratory Monitors
      • 1.2.3. Air Quality Monitors
    • 1.3. Advantages of Monitoring Wearables
    • 1.4. Adoption Drivers and Challenges
      • 1.4.1. Drivers
      • 1.4.2. Challenges
  • 2. CHRONIC RESPIRATORY DISEASE WEARABLES MARKET
    • 2.1. Device Shipments
    • 2.2. Device Revenue
      • 2.2.1. Device ASPs
    • 2.3. Regional Forecasts
  • 3. VENDOR LANDSCAPE
    • 3.1. Pulse Oximeters
      • 3.1.1. Aseptika
      • 3.1.2. iHealth
      • 3.1.3. Nonin Medical
      • 3.1.4. Oxitone Medical
      • 3.1.5. True Wearables
    • 3.2. Respiratory Monitors
      • 3.2.1. Health Care Originals
      • 3.2.2. Philips Healthcare
      • 3.2.3. Propeller Health
      • 3.2.4. Quvium
      • 3.2.5. Respiri
      • 3.2.6. Sparo Labs
      • 3.2.7. SPIRE
      • 3.2.8. Vital Connect
    • 3.3. Air Quality Monitors
      • 3.3.1. NotAnotherOne
      • 3.3.2. TZOA
    • 3.4. Cloud Platforms
      • 3.4.1. Ideal Life
      • 3.4.2. PhysIQ
      • 3.4.3. Qualcomm Life
      • 3.4.4. Spirit Healthcare

 

ページTOPに戻る

プレスリリース

[プレスリリース原文]

Device Connectivity Set to Drive Major Care Change for Millions of COPD Patients

Chronic Respiratory Wireless Pulse Oximeters Shift from the Finger to the Wrist

London, United Kingdom - 08 Feb 2017

 

Chronic respiratory diseases—asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD)—affect up to one billion patients globally. While in the past, clinicians monitored patients’ vitals through regular checkups, new wearable technology now allows them to track this information remotely. ABI Research forecasts device connectivity will drive new chronic respiratory disease wearable form factors, with shipments to grow from three million shipments in 2017 to 12 million in 2022.

COPD, alone, costs U.S. healthcare systems $50 billion per year. ABI Research forecasts the U.S. will spend the most on chronic respiratory disease wearables, accounting for $6 million in 2022 of $21 million in global market revenues. Following the U.S., Europe and the Asia Pacific will also see high adoption rates. As the nascent market gains momentum, the devices will gradually shift from wireless finger-clips to wrist-worn devices.

“Wrist-worn chronic respiratory disease wearables are the ideal form factor, because they allow patients to carry out daily activities uninterrupted while collecting data continuously and in real time to note any subtle fluctuations in oxygen levels,” says Stephanie Lawrence, Research Analyst at ABI Research. “Finger-clip devices must be manually attached and activated throughout the day to provide one-off readings. Though they still provide more information than pulse oximeters in a clinical setting, finger-clip devices often miss subtle fluctuations that could indicate worsening conditions.”

Non-invasive medical monitoring solutions developer Nonin Medical’s latest wrist-worn pulse oximeter—WristOx 2, Model 3150—measures patients’ oxygen saturation and pulse rates, transmitting the data using Bluetooth 2.0. Additionally, medical device manufacturer and startup Oxitone Medical recently released its Oxitone wrist pulse oximeter that continuously monitors blood oxygen levels and sends the data to an app via embedded Bluetooth Smart.

Challenges vendors need to overcome as the market develops include meeting medical regulatory standards. The mandatory standards are critical, as they are clear proof that the device is an effective and accurate form of monitoring a patient’s condition. As obtaining medical regulation is a lengthy process, manufacturers must consider it in the early design stage as the global market develops.

These findings are part of ABI Research’s Chronic Respiratory Disease: Wearable mHealth Device Market Overview report.

 

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る